Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$22.80 USD
+2.30 (11.22%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $22.73 -0.07 (-0.31%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth A Momentum A VGM
Hims & Hers Health, Inc. (HIMS) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$20.33 | $28.00 | $13.00 | -0.83% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Hims & Hers Health, Inc. comes to $20.33. The forecasts range from a low of $13.00 to a high of $28.00. The average price target represents a decline of 0.83% from the last closing price of $20.50.
Analyst Price Targets (15)
Broker Rating
Hims & Hers Health, Inc. currently has an average brokerage recommendation (ABR) of 2.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.20 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, five are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 33.33% and 13.33% of all recommendations. A month ago, Strong Buy made up 33.33%, while Buy represented 13.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 6 |
Buy | 2 | 2 | 2 | 2 | 1 |
Hold | 8 | 8 | 8 | 8 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.20 | 2.20 | 2.20 | 2.20 | 2.07 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/3/2024 | Not Identified | Not Identified | Hold | Hold |
8/22/2024 | Needham & Company | Ryan Macdonald | Not Available | Moderate Buy |
8/9/2024 | Imperial Capital | Michael Piccolo | Strong Buy | Hold |
8/7/2024 | Not Identified | Not Identified | Hold | Hold |
8/6/2024 | Seaport Research Partners | Aaron Kessler | Strong Buy | Strong Buy |
8/6/2024 | Piper Sandler | Korinne N Wolfmeyer | Hold | Hold |
7/18/2024 | Truist Securities | Jailendra Singh | Hold | Hold |
7/11/2024 | Cowen & Co. | Jonna Kim | Strong Buy | Strong Buy |
6/17/2024 | SVB Securities | Michael Cherny | Hold | Hold |
4/10/2024 | Canaccord Genuity | Maria Ripps | Not Available | Strong Buy |
3/15/2024 | Robert W. Baird & Co. | Vikram Kesavabhotla | Hold | Hold |
2/27/2024 | Guggenheim Securities | Jack D Wallace | Strong Buy | Strong Buy |
1/5/2024 | Tigress Financial Partners | Ivan Feinseth | Moderate Buy | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.20 |
ABR (Last week) | 2.20 |
# of Recs in ABR | 15 |
Average Target Price | $20.33 |
LT Growth Rate | NA |
Industry | Medical Info Systems |
Industry Rank by ABR | 74 of 252 |
Current Quarter EPS Est: | 0.06 |
HIMS FAQs
Hims & Hers Health, Inc. (HIMS) currently has an average brokerage recommendation (ABR) of 2.20 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms.
The average price target for Hims & Hers Health, Inc. (HIMS) is $20.33. The current on short-term price targets is based on 7 reports.
The forecasts for Hims & Hers Health, Inc. (HIMS) range from a low of $13 to a high of $28. The average price target represents a decline of $0.83 from the last closing price of $20.50.
The current DOWNSIDE for Hims & Hers Health, Inc. (HIMS) is 0.83%
Based on short-term price targets offered by 15 analysts, the average price target for Hims & Hers Health, Inc. comes to $20.33. The forecasts range from a low of $13.00 to a high of $28.00. The average price target represents a decline of 0.83% from the last closing price of $20.50.